NCR2 and colorectal cancer: Similarly, we found an increased frequency of NK cells expressing the activating NCR NKp44 in STS patients, while studies in peripheral blood of patients with other malignancies, such as colorectal cancer, pancreatic cancer, and gastric cancer, have reported decreased expression of NCR [38,39,40].